Distressed vs solvent acquisition — a UK side-by-side
21 axes compared: price, speed, warranties, TUPE, tax, financing, licences, brand and return. Not every deal should be a bargain — but every buyer should know which structure fits.
21-axis comparison
| Axis | Distressed (admin) | Solvent M&A | Edge |
|---|---|---|---|
| Typical EBITDA multiple (UK SME 2026) | 0.5×–2.5× | 3×–8× | Distressed |
| Time from LOI to completion | 3 days – 6 weeks | 12–20 weeks | Distressed |
| Seller warranties | Title only | Full commercial + tax + IP | Solvent |
| W&I insurance premium | 3–6% of limit (synthetic) | 0.8–1.5% of limit | Solvent |
| Employee liabilities (TUPE) | Reg 8(6) shifts £000s to RPS up to £719/wk | Full transfer under Reg 4 | Distressed |
| Historic corporation tax losses | Lost (asset sale) | Preserved under s.673 rules on share sale | Solvent |
| VAT treatment | TOGC if conditions met, else 20% | TOGC or share sale — no VAT | Neutral |
| SDLT / stamp duty | 0.5% SDRT (shares) or SDLT on property only | Same regime — but higher deal value | Neutral |
| Working-capital adjustment | Rare — locked box | Completion accounts standard | Solvent |
| Financing available | ABL + mezz + equity (fast) | Term debt + ABL + PE (slower) | Distressed |
| Earn-outs / deferred | Almost never | 40–60% of deals | Solvent |
| Customer contract continuity | Change-of-control triggers on ~50% | Consent-only typically, less friction | Solvent |
| IP transfer clarity | Asset assignment via SPA schedules | Automatic in share deal | Solvent |
| Brand equity impact | Net-negative in retail/hospitality; neutral in B2B | Preserved | Solvent |
| Regulatory licence transfer | Requires re-application (CQC, FCA) | Notification only in share deal | Solvent |
| Corporation tax on gains | Buyer capitalises consideration; no seller tax friction | Seller may push for BADR/CGT structuring | Neutral |
| Landlord consent friction | High — assignment or new lease each site | Low (share sale) — high (asset sale) | Solvent |
| Working with the counterparty | Administrator's fiduciary duty is to creditors, not you | Seller aligned with a smooth close | Solvent |
| Reputational risk to buyer | Moderate — press attention on rescue | Low | Solvent |
| Bidder competition | 1–5 approved bidders | 3–15 in an open process | Neutral |
| Return on capital (Sell Ltd deal data) | Median 22-month payback | Median 5.2-year payback | Distressed |
Source: Sell Ltd deal register 2023–2025, Companies House filings, The Gazette insolvency notices, UK Insolvency Service published data.
Which is right for you — a decision tree
Pick distressed if: you have committed capital in 21 days, tolerance for 15–30% customer attrition, a 100-day rescue skillset, and cash-on-cash return matters more than IRR stability.
Pick solvent if: you want full warranties, are financing through term debt or PE, need corporation-tax-loss preservation, or the target's brand equity is the whole thesis.
Consider hybrid if: the target is 'wobbly-solvent' — a CVA target or a company with cashflow strain but no administrator appointed. Structure a solvent deal with insolvency-conditional protections.
What Chris says
"Every buyer wants distressed pricing with solvent risk. That deal doesn't exist. Pick the structure that fits your capital, your speed and your operating team — and stop shopping for the version that's cheaper AND safer."— Chris, AI deal adviser at Sell Ltd
Related
Frequently asked questions
When is a distressed acquisition the right choice?
When you can (a) mobilise cash in 21 days, (b) tolerate zero seller warranties (or afford synthetic W&I at 3–6%), (c) manage TUPE + customer continuity personally in the first 100 days, and (d) accept 15–30% customer attrition in year one. Distressed is a discipline, not a discount.
When is a solvent acquisition the right choice?
When the target is genuinely healthy, the seller wants a clean exit, and you need full commercial warranties and financing runway. Solvent M&A costs 3–5× more but gives you 90% of what you were shown at completion, not 60%.
How much cheaper are distressed deals really?
50–75% of a solvent multiple in the same sector after adjusting for landed cost — ROT strip, above-cap TUPE, IP legal, landlord consent. Sell Ltd's ~180-deal register shows the median distressed enterprise value settles at 40% of the seller's pre-distress arms-length valuation.
Can I combine distressed and solvent M&A in one deal?
Occasionally — a solvent buyer acquires the healthy OpCo via administration to shed liabilities. Common in retail restructurings ('phoenixing' where connected-party rules and SIP 16 Pre-Pack Pool oversight apply). Not a shortcut — HMRC and creditors scrutinise heavily.
How does financing differ?
Distressed: ABL/mezz in 10–21 days. Solvent: term debt / unitranche / private-equity capital in 45–90 days. Distressed deals rarely support >4× leverage; solvent deals can push 5–7×. See the financing guide.
Are the returns really higher in distress?
On paid-in capital, usually yes — Sell Ltd's data shows median 22-month payback on distressed acquisitions vs 5.2 years on comparable solvent deals. But volatility is higher: standard deviation of outcomes is ~2× the solvent set. Higher return, materially higher risk.
What about tax efficiency?
Solvent share deals preserve corporation tax losses (subject to CTA 2010 s.673) and can be structured for BADR at 10% for individual sellers. Distressed asset sales lose all seller-side reliefs — the losses die with the old company, no tax shield transfers.
How does the counterparty dynamic differ?
In solvent M&A, the seller wants to close. In distressed, the administrator wants the highest defensible price under SIP 16 with proof it went to creditors. That means: no soft-touch on price, hard evidence of funds, no 'subject to' conditions.
What if the target is 'distressed but not administered'?
This is the accommodation zone — a company under CVA (Company Voluntary Arrangement) or with a serious cash-flow issue but not yet insolvent. Structure as a solvent deal with insolvency-conditional protections: enhanced warranties, deep escrow, and a pre-emptive administration filing under s.1(A) IA 1986 as a fallback.
How do I decide between the two?
Ask three questions: (1) Is time-to-close the constraint or is deal quality? (2) Do I have committed capital in 21 days or committed capital in 90 days? (3) Can I run a 100-day rescue playbook or do I need a stable trading platform on day one? Answering these picks the structure for you.